Uterine fibroids are extremely prevalent in women of reproductive age, and it not only causes abnormal vaginal bleeding, but may also trigger a variety of reproductive diseases, which seriously affect patients' health. High intensity focused ultrasound (HIFU) is a micro noninvasive procedure with the advantages of being noninvasive and preserving the uterus, providing a new option for women of reproductive age. However, HIFU has a high rate of long-term re intervention and carries a risk of recurrence, and the use of magnetic resonance imaging (MRI) to effectively assess the efficacy and safety of HIFU ablation of uterine fibroids can be used for preoperative safety assessment and efficacy prediction, intraoperative monitoring, postoperative efficacy assessment, and postoperative re intervention and local recurrence. In this article, the recent progress of magnetic resonance in the treatment of uterine fibroids with HIFU is reviewed.

Yue Wenjing, Ban Yunqing. The advantages of focused ultrasound ablation for uterine fibroids and the use of MRI in management. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 9: 122-128. https://doi.org/10.25236/IJFM.2023.050920.

[1] Chinese expert consensus expert group on the diagnosis and treatment of uterine fibroids Chinese expert consensus on the diagnosis and treatment of uterine fibroids [J] Chinese Journal of Obstetrics and Gynecology, 2017, 52 (12): 793-800 

[2] STEWART E, COOKSON C, GANDOLFO R, et al. Epidemiology of uterine fibroids: a systematic review [J]. BJOG : an international journal of obstetrics and gynaecology, 2017, 124(10): 1501-12.

[3] Liu Haihong, Shi Xiaorong. Research progress in the treatment of uterine fibroids with high intensity focused ultrasound [J] International Journal of Obstetrics and Gynecology, 2022, 49 (5): 540-4,64

[4] KIM Y, KIM K, LEE S, et al. Preoperative 3-dimensional Magnetic Resonance Imaging of Uterine Myoma and Endometrium Before Myomectomy [J]. Journal of minimally invasive gynecology, 2017, 24(2): 309-14.

[5] LYNN J, ZWEMER R, CHICK A, et al. A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY [J]. The Journal of general physiology, 1942, 26(2): 179-93.

[6] ELHELF I, ALBAHAR H, SHAH U, et al. High intensity focused ultrasound: The fundamentals, clinical applications and research trends [J]. Diagnostic and interventional imaging, 2018, 99(6): 349-59.

[7] SHAW A, TER HAAR G. Requirements for Measurement Standards in HIFU Fields. NPL Report DQL AC015: [S]. 2006: 

[8] Lin Jingxia, Mali Research progress on treatment methods for submucosal fibroids of the uterus [J] Chinese Modern Doctor, 2017, 55 (2): 161-4

[9] Liu Yaxian, Lan Shuhai Research progress on the pharmacological mechanism and clinical application of mifepristone in the treatment of uterine fibroids [J] Chinese Journal of Drug Abuse Prevention and Control, 2022, 28 (10): 1354-7

[10] JENG C J, OU K Y, LONG C Y, et al. 500 Cases of High-intensity Focused Ultrasound (HIFU) Ablated Uterine Fibroids and Adenomyosis [J]. Taiwan J Obstet Gynecol, 2020, 59(6): 865-71.

[11] YU S C, CHEUNG E C, LEUNG V Y, et al. Oxytocin-Augmented and Non-Sedating High-Intensity-Focused Ultrasound (HIFU) for Uterine Fibroids Showed Promising Outcome As Compared To HIFU Alone or Uterine Artery Embolization [J]. Ultrasound Med Biol, 2019, 45(12): 3207-13.

[12] TONGUC T, RECKER F, GANSLMEIER J, et al. Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids [J]. Scientific reports, 2022, 12(1): 21155.

[13] LI F, CHEN J, YIN L, et al. HIFU as an alternative modality for patients with uterine fibroids who require fertility-sparing treatment [J]. Int J Hyperthermia, 2023, 40(1): 2155077.

[14] AKHATOVA A, AIMAGAMBETOVA G, BAPAYEVA G, et al. Reproductive and Obstetric Outcomes after UAE, HIFU, and TFA of Uterine Fibroids: Systematic Review and Meta-Analysis [J]. Int J Environ Res Public Health, 2023, 20(5).

[15] GIULIANI E, AS-SANIE S, MARSH E E. Epidemiology and management of uterine fibroids [J]. Int J Gynaecol Obstet, 2020, 149(1): 3-9.

[16] DEMULDER D, ASCHER S M. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment? [J]. AJR Am J Roentgenol, 2018, 211(6): 1405-15.

[17] LIN Y, WU R C, HUANG Y L, et al. Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis [J]. Abdom Radiol (NY), 2022, 47(6): 2197-208.

[18] WANG Q, WU X, ZHU X, et al. MRI features and clinical outcomes of unexpected uterine sarcomas in patients who underwent high-intensity focused ultrasound ablation for presumed uterine fibroids [J]. Int J Hyperthermia, 2021, 38(2): 39-45.

[19] ABDEL WAHAB C, JANNOT A S, BONAFFINI P A, et al. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI [J]. Radiology, 2020, 297(2): 361-71.

[20] WANG C, ZHENG X, ZHOU Z, et al. Differentiating cellular leiomyoma from uterine sarcoma and atypical leiomyoma using multi-parametric MRI [J]. Front Oncol, 2022, 12: 1005191.

[21] HéLAGE S, VANDEVENTER S, BUY J N, et al. Uterine Sarcomas: Are There MRI Signs Predictive of Histopathological Diagnosis? A 50-Patient Case Series with Pathological Correlation [J]. Sarcoma, 2021, 2021: 8880080.

[22] VIRARKAR M, DIAB R, PALMQUIST S, et al. Diagnostic Performance of MRI to Differentiate Uterine Leiomyosarcoma from Benign Leiomyoma: A Meta-Analysis [J]. J Belg Soc Radiol, 2020, 104(1): 69.

[23] ZHAO W P, CHEN J Y, CHEN W Z. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation [J]. Ultrasound Med Biol, 2015, 41(2): 423-31.

[24] ZHAO W P, ZHANG J, HAN Z Y, et al. A clinical investigation treating different types of fibroids identified by MRI-T2WI imaging with ultrasound guided high intensity focused ultrasound [J]. Sci Rep, 2017, 7(1): 10812.

[25] WANG Y, GONG C, HE M, et al. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images [J]. Int J Hyperthermia, 2023, 40(1): 2194594.

[26] YANG M J, YU R Q, CHEN W Z, et al. A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids [J]. Front Surg, 2021, 8: 663128.

[27] SIEDEK F, YEO S Y, HEIJMAN E, et al. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU): Technical Background and Overview of Current Clinical Applications (Part 1) [J]. Rofo, 2019, 191(6): 522-30.

[28] HIJNEN N, LANGEREIS S, GRüLL H. Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery [J]. Advanced drug delivery reviews, 2014, 72: 65-81.

[29] YU L, ZHU S, ZHANG H, et al. The efficacy and safety of MR-HIFU and US-HIFU in treating uterine fibroids with the volume <300 cm(3): a meta-analysis [J]. Int J Hyperthermia, 2021, 38(1): 1126-32.

[30] ZHANG D L, WU S S, CHEN S, et al. Differences in the therapeutic effects of high-intensity focused ultrasound (HIFU) ablation on uterine fibroids with different shear wave velocity (SWV): a study of histopathological characteristics [J]. Int J Hyperthermia, 2020, 37(1): 1322-9.

[31] Cun Jiangping, Fan Hongjie, Zhao Wei, et al. Evaluation of the efficacy of HIFU ablation for uterine fibroids using non perfusion MR T2WI signal [J] Chinese Medical Imaging Technology, 2018, 34 (9): 1381-5

[32] JIANG L, YU J W, YANG M J, et al. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: A propensity score matched cohort study [J]. Front Surg, 2022, 9: 975839.

[33] LIAO D, XIAO Z, LV F, et al. Non-contrast enhanced MRI for assessment of uterine fibroids' early response to ultrasound-guided high-intensity focused ultrasound thermal ablation [J]. European journal of radiology, 2020, 122: 108670.

[34] ZHAO W, CHEN J, CHEN W. Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images [J]. Experimental and therapeutic medicine, 2016, 11(1): 328-34.